Aura Biosciences, Inc.
AURA
$7.93
-$0.26-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -106.19M | -106.47M | -101.38M | -94.70M | -86.92M |
| Total Depreciation and Amortization | 1.13M | 1.15M | 1.18M | 1.21M | 1.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.35M | 13.62M | 11.96M | 10.20M | 8.53M |
| Change in Net Operating Assets | 5.97M | 3.47M | 4.89M | 4.58M | -2.64M |
| Cash from Operations | -84.74M | -88.23M | -83.35M | -78.71M | -79.81M |
| Capital Expenditure | -447.00K | -570.00K | -866.00K | -1.35M | -1.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.04M | 36.04M | 90.24M | 90.59M | 70.07M |
| Cash from Investing | 35.60M | 35.47M | 89.37M | 89.24M | 68.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.75M | 51.52M | 47.87M | 1.44M | 1.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.41M | 23.41M | 23.41M | -- | -- |
| Cash from Financing | 77.16M | 74.93M | 71.28M | 1.44M | 1.60M |
| Foreign Exchange rate Adjustments | -186.00K | -26.00K | -12.00K | -21.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.82M | 22.15M | 77.29M | 11.95M | -9.39M |